GSK is experiencing growth amidst challenges, with a 13% sales increase and R&D innovations. However, facing declining U.S. vaccine sales and legal issues, GSK must manage risks carefully. Strategic opportunities like new vaccine launches and alliances position GSK for future success, despite external threats.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing